More and more markets require certain drugs to be serialised. Pharmaceutical manufacturers should not lose sight of the opportunities arising from this obligation. In this interview, Simon Cole, sales executive at Atlantic Zeiser UK, points out why blockchain is gaining importance in track & trace systems, and what effects can be expected from Brexit.
Blockchain
Q. What are the benefits of Track & Trace systems to pharma companies and their customers?